Related Stories

With FTC Rule in Limbo, Texas Legislature to Reconsider Noncompetes - 09/20/2024

Amid a pair of conflicting court rulings – one of which blocked a Federal Trade Commission (FTC) final rule banning most noncompete clauses – the Texas Senate is pondering related legislation for the upcoming session that could impact a significant number of physicians statewide.


Meet Opioid Training Mandates With CME From TMA - 08/29/2024

Through the Texas Medical Association, physicians can play a part in curbing rates of opioid overdose and substance use disorder – and meet state and federal agencies’ CME mandates.


Risk Management - 08/15/2024

Practice e-Tips on Risk Management


TMA Wins Appeal Upholding Its Challenge to Skewed Federal Surprise Billing Rule - 08/05/2024

A federal appeals court handed a victory to medicine affirming the district court’s decision to strike down federal provisions that run counter to Congress' intent for implementing a key piece of the No Surprises Act: to operate an arbitration process that does not skew dispute resolutions and unfairly advantage health plans. Read more.


Effects of Opioids and Nonsteroidal Anti-Inflammatory Drugs on Chronic Low Back Pain and Related Measures: Results from the PRECISION Pain Research Registry - 07/30/2024

Measuring treatments used by 202 patients with chronic low back pain in the PRECISION Pain Research Registry, this study determined the associations of opioid and nonsteroidal anti-inflammatory drug (NSAID) therapy with clinical status. More than one-fourth of patients did not use nonpharmacologic treatments for low back pain. Patients age 50-59 and 60-79 years old were more likely to use opioids than younger patients. Patients using opioids reported greater pain and back-related disability than did patients using NSAIDs. Patients concurrently using opioids and NSAIDs reported greater back-related disability and poorer quality of life than did patients using no or other pharmacologic therapy. No significant associations between pharmacologic therapy and clinical status remained after controlling for potential confounders. Neither opioids nor opioids combined with NSAIDs were more effective than just NSAIDs. Greater use of nonpharmacologic therapies and better second-line, nonopioid ph...


Keep Them From Harm and Injustice? - 07/30/2024

Fear remains a major barrier to transparency of hospital errors.


More Work Needed to Protect Texas Physicians - 06/28/2024

Following the Texas Medical Board’s newly adopted rules on abortion ban exceptions, the Texas Medical Association continues its advocacy for physicians performing abortions to treat a medical emergency under the state’s overlapping abortion laws.


New TMA Policy: Reduce Fentanyl Overdoses with Improved Naloxone Access - 06/24/2024

Over a 27-hour period this spring, the city of Austin saw nine people die across 79 separate overdose incidents, reflecting the severity of the statewide fentanyl crisis. Policy approved by the Texas Medical Association’s House of Delegates in May anticipated the problem and promotes one of the most effective solutions – increased education about and distribution of naloxone, an opioid overdose reversal drug.


TMB Proposed Rules on Abortion Ban Exceptions Invite TMA Opposition - 05/14/2024

The Texas Medical Board (TMB) recently released proposed rules intended to clarify exceptions to the state’s overlapping abortion laws. But TMA argues the proposal could exacerbate physician confusion, administrative burden on practices, and patient care delays. Read more.


Fingerprinting Services to Be Offered at TexMed - 04/18/2024

Because many Texas physicians now are required to provide fingerprints to renew their medical licenses, the Texas Medical Association has contracted with Idemia to make these services available onsite at TexMed 2024 for registered conference attendees.


Seeking Balance: TMA Opposes Feds' Implementation of the No Surprises Act - 04/09/2024

The Texas Medical Association supported the patient protections in the federal No Surprises Act but also knew from the beginning that the law's payment arbitration provisions were flawed and could give insurers an advantage.


RICO Settlements: TMA's Leadership Against Payer Abuses Resulted in Relief, Reform - 04/09/2024

Back in 2001, the Texas Medical Association and the other plaintiffs alleged the nation’s major health plans had conspired to delay and reduce payments to clinicians and hospitals; the resulting lawsuits, brought under the federal Racketeer Influenced and Corrupt Organizations Act (RICO), represented a watershed moment in TMA history.


UPDATE: TMB Continues to Clarify New Fingerprinting Requirement Ahead of License Renewals - 03/11/2024

As the first round of this year’s physician licensure renewals get under way, a new fingerprinting requirement affecting certain renewals has sparked confusion and concern among Texas physicians.


Exceptional Circumstances: TMA Advocates “Legislative Clarity” Amid State Abortion Bans - 03/05/2024

TMA advocates “legislative clarity” amid state abortion bans.


Physicians’ DEA Registration Now Requires Training on Substance Use Disorder - 01/03/2024

Physicians who must register or renew their registration for a Drug Enforcement Administration license will face a new requirement as of June 27: To register, they will have attest to taking a one-time, eight-hour training on how to treat patients with opioid or other substance use disorders.


TMB to Start One-Time Fingerprinting Requirements for License Renewals - 11/15/2023

Approximately 75,000 Texas physicians seeking to renew their medical license soon will be required to submit their fingerprints, according to the Texas Medical Board.


Feds Extend Telemedicine Prescribing Flexibilities Through 2024 - 11/10/2023

With permanent telehealth prescribing policies still under consideration, the U.S. Drug Enforcement Administration (DEA) again has extended temporary pandemic-era telehealth flexibilities to allow physicians to virtually prescribe certain controlled medications, now through Dec. 31, 2024.


CDC Grant Funds Drug Overdose Data Collection in Texas - 10/30/2023

A nearly $4 million grant from the Centers for Disease Control and Prevention could give Texas physicians new tools to handle national opioid and mental health crises, which have made it difficult to identify patients at risk for substance use disorders.


Help Promote National Drug Prescription Take Back Day on Oct. 28 - 10/19/2023

Prescription Drug Take Back Day, which allows people to dispose of prescription drugs safely and anonymously, is scheduled for Oct. 26 at locations throughout the state.


Noncompete Concerns Spark Ongoing TMA Advocacy, Resources - 09/19/2023

The Texas Medical Association continues to receive reports of physician concerns over noncompete agreements, underscoring medicine’s ongoing legislative and regulatory advocacy efforts to strike a balance that works for physician employers and employed physicians alike.


Physicians Warn: New Drug Overdose Threat Contains Veterinary Tranquilizer Xylazine - 09/18/2023

Xylazine, a tranquilizer used in veterinary medicine, is appearing in illicit street drugs with fentanyl, compounding the dangers of the opioid overdose epidemic. Xylazine, also called “tranq” according to the U.S. Drug Enforcement Administration, is used to tranquilize animals. It is not approved for human use and has killed people who have taken the drug.


Physicians Alarmed by Sharp Spike in Accidental Overdose Deaths Fueled by Illegal Drugs - 09/18/2023

A surge in accidental opioid overdose deaths in Texas is showing no signs of slowing down, and Texas physicians warn the rise in illegally produced drugs laced with fentanyl are to blame. They also say increasing the availability of life-saving, overdose-reversing drugs like naloxone, as well as addiction treatment programs, can help.


Physicians Urge Texans to Safely Return Unused Prescription Medication - 09/18/2023

Texas physicians recommend people with unused or expired prescription drugs at home dispose of them safely this weekend, so they are not accidently consumed. The U.S. Drug Enforcement Administration is organizing its biannual prescription drug Take Back Day on Saturday, Oct. 29. Prescription drugs can be returned anonymously at pop up locations across the state.


Medical Board Renewed; Special Session Ends - 08/23/2023

The 85th Texas Legislature returned to Austin July 18 for its first called special session. Senate and House members, led by Lt. Gov. Dan Patrick and Speaker Joe Straus, have 30 days to address the 20 topics identified by Gov. Greg Abbott starting with the Texas Medical Board sunset bill and other sunset legislation.


Opioids: Resources for Prescribing and Addiction Treatment - 07/20/2023

Get access to information about medication-assisted treatment for opioid use disorder. Online resources for prescribing opioids appropriately also are available.